Overview
Muscular ossification is a disorder.
Auto-generated from clinical reference data. Not a substitute for medical advice.
Research Evidence
Peer-reviewed studies linked via MeSH term "Myositis Ossificans" from the MEDLINE/PubMed database.
Sort:
Understanding the clinical morbidity and mortality of fibrodysplasia ossificans progressiva: a systematic literature review.
[object Object], [object Object], [object Object] et al. · Orphanet J Rare Dis · 2025
The anatomical basis for surgical intervention in myositis ossificans-A systematic review.
[object Object], [object Object], [object Object] et al. · Clin Anat · 2025
PMID: 39623749Meta-Analysis
Progressive osseous heteroplasia in a 5-year-old boy with a novel mutation in exon 2 of GNAS: a case presentation and literature review.
[object Object], [object Object], [object Object] et al. · BMC Musculoskelet Disord · 2023
A Clinical Perspective on Advanced Developments in Bone Biopsy Assessment in Rare Bone Disorders.
[object Object], [object Object], [object Object] et al. · Front Endocrinol (Lausanne) · 2020
FOP in China and Japan: an overview from domestic literatures.
[object Object], [object Object], [object Object] et al. · Am J Med Genet A · 2013
PMID: 23444029Meta-Analysis
Comparison of PET/CT versus CT only in the assessment of new heterotopic ossification bone lesions in patients with fibrodysplasia ossificans progressiva.
[object Object], [object Object], [object Object] et al. · Bone · 2025
PMID: 39395655RCT
Characterization of flare-ups and impact of garetosmab in adults with fibrodysplasia ossificans progressiva: a post hoc analysis of the randomized, double-blind, placebo-controlled LUMINA-1 trial.
[object Object], [object Object], [object Object] et al. · J Bone Miner Res · 2024
Garetosmab in Fibrodysplasia Ossificans Progressiva: Clinical Pharmacology Results from the Phase 2 LUMINA-1 Trial.
[object Object], [object Object], [object Object] et al. · J Clin Pharmacol · 2024
PMID: 37694449RCT
Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial.
[object Object], [object Object], [object Object] et al. · Nat Med · 2023
Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP): Results of a Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial.
[object Object], [object Object], [object Object] et al. · J Bone Miner Res · 2022
PMID: 35854638RCT
Search all PubMed articles for Muscular ossification
Research data from MEDLINE/PubMed
Related Conditions
Secondary ossification of muscle(child)
Paralytic calcification / ossification of muscle(child)
Progressive myositis ossificans(child)
Progressive osseous heteroplasia(child)
Idiopathic muscular ossification(child)
Nontraumatic myositis ossificans circumscripta(child)
Calcification of muscle(parent)
Heterotopic ossification(parent)
Quick Facts
- SNOMED CT
- 44551007
- UMLS CUI
- C0027122
- Fully Specified Name
- Muscular ossification (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.